Milestones in the development of pediatric hematopoietic stem cell transplantation - 50 Years of progress

Pediatric Transplantation

Volumn 6, Issue 6, 2002, Pages 465-474

  Trigg, Michael E ^a,b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Blood formation; Pediatrics; Stem cell transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; CHILDHOOD LEUKEMIA; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; INFUSION; LEUKEMIA; NEUROBLASTOMA; ORGAN DONOR; PATIENT SELECTION; REVIEW; SOLID TUMOR; UMBILICAL CORD; UMBILICAL CORD BLOOD;

BONE MARROW TRANSPLANTATION; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TISSUE DONORS;

EID: 0036905694     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.00022.x     Document Type: Review

References (55)

1. Cavins JA, Scheer SC, Thomas ED, Ferrebee JW. The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at - 80°C. Blood 1964: 23: 8-43.
2. Ford CE, Hamerton JL, Barnes DWH, Loutit FJ. Cytological identification of radiation-chimaeras. Nature 1956: 177: 452-454.
3. Jacobson LO, Marks EK, Robson MJ, Gaston EO, Zirkle RE. Effect of spleen protection on mortality following x-irradiation. J Clin Med 1949: 34: 1538-1543.
4. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury on mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951: 12: 197-201.
5. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage x radiation and homologous bone marrow. J Natl Cancer Inst 1955: 15: 1023-1029.
6. Mannick JA, Lochte HL Jr, Ashley CA, Thomas ED, Ferrebee JW. Autografts of bone marrow in dogs after lethal total-body radiation. Blood 1960: 15: 255-266.
7. Thomas ED, Collins JA, Herman EC Jr, Ferrebee JW. Marrow transplants in lethally irradiated dogs given methotrexate. Blood 1962: 19: 217-228.
8. Mathe G, Amiel JL, Schwarzenberg L, Catton A, Schneider M. Adoptive immunotherapy of acute leukemia: Experimental and clinical results. Cancer Res 1965: 25: 1525-1531.
9. Santos GW, Owens AH Jr. Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc The 1969: 1: 44-46.
10. Storb R, Epstein RB, Graham TC, Thomas ED. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970: 9: 240-246.
11. Thomas ED, Lochte HL Jr, Cannon JH, Sahler OD, Ferrebee JW. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959: 38: 1709-1716.
12. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957: 257: 491-496.
13. Trigg ME. The sources and uses of hematopoietic stem cells keep increasing. Del Med J 1998: 70: 387-392.
14. Good RA, Verjee T. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Bone Marrow Transpl 2001: 7: 123-135.
15. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995: 346: 214-219.
16. Thomas ED, Blume KG. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Bone Marrow Transpl 1999: 5: 341-346.
17. Thomas ED, Flournoy N, Buckner CD, et al. Cure of leukemia by marrow transplantation. Leuk Res 1977: 1: 67-70.
18. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med 1975: 292: 832-843, 895-902.
19. Krivan G, Timar L, Goda V, et al. Bone marrow transplantation in non-malignant disorders. Bone Marrow Transpl 1998: 22 (Suppl. 4): S80-S83.
20. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000: 343: 1313-1324.
21. Moen RC, Horowitz SD, Sondel PM, et al. Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders. Treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 1987: 70: 664-669.
22. Wheeler KA, Richards SM, Bailey CC, et al. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission. Results from Medical Research Council UKALL X and XI. Blood 2000: 96: 2412-2418.
23. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia. Leukemia, 1983-95: 14: 2223-2233. 2000.
24. Harrison G, Richards S, Lawson S, et al. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukemia in the MRC UKALL R1 trial. Biol Oncol 2000: 11: 999-1006.
25. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: A report from the Children's Cancer Group. Blood 2001: 97: 56-62.
26. Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996: 14: 2417-2426.
27. Seeger RC, Reynolds P, Gallego R, et al. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in Stage IV neuroblastoma: A Children's Cancer Group study. J Clin Oncol 2000: 18: 4067-4076.
28. Trigg ME, Gingrich R, Goeken N, et al. Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation. Bone Marrow Transpl 1989: 4: 431-437.
29. Trigg ME, Peterson A, Erickson C, et al. Depletion of T cells from bone marrow for allogeneic transplantation: Method for treatment of bone marrow in bulk. Exp Hematol 1986: 14: 21-26.
30. Trigg ME. Bone marrow transplantation using alternative donors. Am J Ped Hematol/Oncol 1993: 15 ((2)): 141-149.
31. Trigg ME, Rumelhart SL, Miller J, et al. Ten-year experience of unrelated bone marrow donor transplants in children with malignant and no-malignant conditions. Pediatr Transp 1999: 3: 49-59.
32. Lowry PA, Tabbara IA. Peripheral hematopoietic stem cell transplantation: Current concepts. Exp Hematol 1992: 20: 937-942.
33. Kletzel M, Longino R, Rademaker AW, et al. Peripheral blood stem cell transplantation in young children: Experience with harvesting, mobilization and engraftment. Pediatr Transpl 1998: 2: 191-196.
34. Bensingur WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001: 344: 175-181.
35. Polmar SH, Schacter BZ, Sorensen RU. Long-term immunological reconstitution by peripheral blood leucocytes in severe combined immune deficiency disease. Implications for the role of mature lymphocytes in histocompatible bone marrow transplantation. Clin Ex Immunol 1986: 64: 518-525.
36. Lickliter JD, McGlave PB, Defor TE, et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transpl 2000: 26: 723-728.
37. Pahwa R, Pahwa S, Good RA, Incefy GS, O'Reilly RJ. Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variatns of severe combined immunodeficiency. Proc Natl Acad Sci USA 1977: 74: 3002-3005.
38. Laughlin MJ, Barker J, Bambach B, Koc ON, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001: 344: 1815-1822.
39. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989: 321: 1174-1178.
40. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood 1995: 86: 2856-2862.
41. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placebal-blood transplants from unrelated donors. N Engl J Med 1998: 339: 1565-1577.
42. Johnson FL. Bone marrow transplantation in the treatment of sickle cell anemia. Am J Pediatr Hem Oncol 1985: 7: 254-257.
43. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996: 335: 369-376.
44. Gore L, Lane PA, Quinones RR, Giller RH. Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: Implications for comprehensive care. J Pediatr Hem Oncol 2000: 22: 437: 140.
45. Fixler J, Vichinsky E, Walters MC. Stem cell transplantation for sickle cell disease: Can we reduce the toxicity? Pediatr Pathol Mol Med 2001: 20: 73-86.
46. Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996: 87: 4894-4902.
47. Drobyski WR, Keever CA, Roth MS. et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose. Blood 1993: 82: 2310-2318.
48. Carlens S, Remerger M, Ashan J, Ringden O. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol Blood Marrow Transpl 2001: 7: 31-38.
49. Aker M, Kapelushnik J, Pugatsch T, et al. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for β-Thalassemia Major. J Pediatr Hem Oncol 1998: 20: 145-148.
50. McSweeney PA, Storb R. Mixed chimerism: Preclinical studies and clinical applications. Biol Blood Marrow Transpl 1999: 5: 192-203.
51. Trigg ME, Schugar R. Chédiak-Higashi syndrome: Hematopoietic chimerism corrects genetic defect. Bone Marrow Transpl Transpl 2001: 27: 1211-1213.
52. Barge RMY, Brouwer RE, B MFC, et al. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation, effect of stem cell source on short- and long-term outcome. Bone Marrow Transpl 2001: 27: 1053-1058.
53. Saarinen-Pihkala UM, Gustafsson G, Ringden O, et al. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol 2001: 19: 3406-3414.
54. Touraine J-L, Raudrant D, Vullo C, et al. New developments in stem cell transplantation with special reference to the first in utero transplants in humans. Bone Marrow Transpl 1991: 7 (Suppl. 3): 92-97.
55. Jones DRE, Bui T-H, Anderson EM, et al. In utero haematopoietic stem cell transplantation: Current perspectives and future potential. Bone Marrow Transpl 1996: 18: 831-837.